Here you can find detailed profiles of DKTK faculty members with programm specification and research focus in the Researcher Database. Find contacts of all DKTK scientists at the DKTK intranet
Researcher Database
Prof. Dr. med. Oliver Weigert
Medizinische Klinik und Poliklinik III LMU Klinikum
Max-Lebsche-Platz 30
81377 München
Programs
Exploitation of Oncogenic Mechanisms (EOM)
Molecularly Targeted Therapy (MTT)
Summary
Oliver Weigert is a physician scientist in the Medical Department III (Hematology & Medical Oncology) at the Hospital of the Ludwig-Maximilians-University (LMU), Munich. He holds a professorship position for Translational Lymphoma Research at the LMU and is co-heading the Laboratory for Experimental Leukemia and Lymphoma Research (ELLF). Furthermore, he is a member of the German Lymphoma Alliance (GLA) and serves as a spokesperson of the working group Biological Research.
Oliver Weigert’s laboratory is largely committed to the molecular characterization and the biology of malignant B-cell lymphomas to develop prognostic and predictive tools for risk- and biology-adapted treatment strategies.